Healthtech Startups
16,890 companies tagged Healthtech, with their investors and founders.
Medo developed an FDA-cleared cloud platform that segmented ultrasound scans into three-dimensional anatomical views and returned findings in seconds. The interface was built so that operators without specialist sonography training could identify a range of common and urgent conditions. Exo acquired the company in 2022.
3 investors
MedPay provides a pharmacy management platform that helps neighborhood pharmacies in India digitize operations, manage inventory, process payments, and engage customers through an all-in-one app.
3 investors
Medplum provides a data infrastructure and interoperability platform for developers building healthcare products and services. The platform offers secure, compliant infrastructure to enable healthcare innovators to develop applications more efficiently.
3 investors
MedPrime builds digital microscopy products, including the CILIKA digital microscope and MICALYS whole slide scanner, with AI-powered imaging for diagnostics, research, and medical education. It serves doctors, pathologists, students, and educators in labs, clinics, and classrooms, primarily in India.
3 investors
Medsien provides remote care management technology for medical providers to deliver chronic care to patients remotely. It serves healthcare practices in the US, targeting the large population of adults living with chronic conditions.
3 investors
Megadata provides a data analytics and business intelligence platform for long-term care and behavioral health organizations, turning operational data into actionable insights. It serves providers in the long-term care and behavioral health sectors.
3 investors
Melio develops a rapid bloodborne pathogen testing platform that identifies common pathogens from blood samples within hours, replacing traditional multi-day culture-based diagnostics.
3 investors
3 investors
Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration. The company operates in the biotechnology and drug development space.
3 investors
Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.
3 investors
MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
3 investors
Micron Agritech develops portable pen-side diagnostic devices for animal health testing, enabling rapid diagnostics for farmers and veterinarians. The Irish company combines software, hardware, and veterinary science to provide digital solutions for the livestock sector.
3 investors
Mighty Health provides a comprehensive health program designed to help older adults maintain and improve their daily functioning and independence.
3 investors
MindFi provides a workplace mental health platform offering employees access to care, practical resources, and organizational insights into workforce wellbeing. The platform serves global companies seeking to integrate mental health support across their operations.
3 investors
Mindpath Health is an independent provider of outpatient mental health care services that aims to expand patient access to mental health treatment. The company is clinically led and operates through a network of care providers serving communities nationwide.
3 investors
Minze Health develops solutions for diagnosing and managing lower urinary tract symptoms (LUTS), such as those caused by benign prostatic hyperplasia (BPH) or overactive bladder (OAB). The company targets the large population of adults affected by urinary conditions in the U.S. and EU.
3 investors
Mirador discovers and develops precision medicines for immune-mediated and immuno-fibrotic diseases using a target-patient matching approach. The company targets therapeutics to improve treatment efficacy beyond current standards in immunology and fibrotic conditions.
3 investors
miraDry provides a non-invasive medical treatment aimed at improving patients' physical and emotional wellbeing, marketed to clinical customers and patients. The company positions itself in the aesthetic/medical device and wellness space.
3 investors
miRecule is a biotechnology company developing therapeutics, with programs focused on oncology. It applies RNA-based drug development approaches within the biotech industry.
3 investors
Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical. The platform serves pregnant women and their healthcare providers to improve maternal and fetal health outcomes.
3 investors
Mitra develops a non-invasive skin diagnostics platform that combines clinical trials, skin sampling, next-generation sequencing, and data science to guide the design of age-rejuvenating skincare compounds. The company applies genomics to skin health and precision dermatological therapies.
3 investors
MiWendo develops an electromagnetic accessory for colonoscopes that automates polyp detection and differentiates benign from malignant tissues to improve early colorectal cancer diagnosis. The device is designed for use in gastroenterology and oncology clinical practices.
3 investors
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
3 investors
Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.
3 investors